|
Volumn 9, Issue 9, 1999, Pages 1926-1931
|
International differences in health care costs in Europe and the United States: Do these affect the cost-effectiveness of diagnostic strategies for pulmonary embolism?
|
Author keywords
Cost effectiveness analysis; Diagnosis; Pulmonary embolism; Radiology
|
Indexed keywords
FIBRINOLYTIC AGENT;
ANGIOGRAPHY;
ARTICLE;
COMPARATIVE STUDY;
COMPUTER ASSISTED TOMOGRAPHY;
COST BENEFIT ANALYSIS;
ECHOGRAPHY;
ECONOMICS;
EUROPE;
FIBRINOLYTIC THERAPY;
HEALTH;
HEALTH CARE COST;
HUMAN;
LUNG EMBOLISM;
PROGNOSIS;
PULMONARY ARTERY;
QUESTIONNAIRE;
RADIOGRAPHY;
SCINTISCANNING;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
STANDARD;
UNITED STATES;
ANGIOGRAPHY;
COST-BENEFIT ANALYSIS;
EUROPE;
FIBRINOLYTIC AGENTS;
HEALTH CARE COSTS;
HUMANS;
PROGNOSIS;
PULMONARY ARTERY;
PULMONARY EMBOLISM;
QUESTIONNAIRES;
THROMBOLYTIC THERAPY;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
TOMOGRAPHY, X-RAY COMPUTED;
ULTRASONOGRAPHY;
UNITED STATES;
WORLD HEALTH;
|
EID: 0033255601
PISSN: 09387994
EISSN: None
Source Type: Journal
DOI: 10.1007/s003300050951 Document Type: Article |
Times cited : (32)
|
References (12)
|